CDK7 and prostate cancer: Moreover, lncRNA SNHG1 negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer [15] and can serve as diagnostic and prognostic markers for prostate cancer through androgen-responsive manner [16].